Media Summary: Presented By: Jenna Frame Speaker Biography: Dr. Jenna Frame has worked with multiple strains of In this webinar, Kaya Gosh, Ph.D., and Cat Chappell, M.S. discuss the most widely used Join Grace Berryhill, Ph.D. and Andrew Schile, Ph.D. as they discuss the considerations in choosing an immunodeficent
Immunodeficient Mouse Models To Support - Detailed Analysis & Overview
Presented By: Jenna Frame Speaker Biography: Dr. Jenna Frame has worked with multiple strains of In this webinar, Kaya Gosh, Ph.D., and Cat Chappell, M.S. discuss the most widely used Join Grace Berryhill, Ph.D. and Andrew Schile, Ph.D. as they discuss the considerations in choosing an immunodeficent Speakers: Dr. Santi Suryani Chen, Associate Director of Immunology and Oncology Dr. Zhiying Li, Directory of Life Science and ... Alexander Michels, Paul-Ehrlich-Institut, Langen, Germany, provides an overview of Federica Benvenuti, ICGEB, Trieste - Italy speaks on "
Juliane Mietz, University Of Zurich, Zurich, Switzerland, describes Join Rick Huntress and Natalie Hurlen, Ph.D. on Wednesday, August 12 as they discuss humanizing The Jackson Laboratory offers more than 7000 genetically defined strains of JAX® Presented at Cancer Research & Oncology 2017: Lee ... November 17, 2020 - Would you like to learn about housing and health considerations related to Speaker: Dr. Jim Jin Dr. Jin received his Ph.D. from Louisiana State University in immunology and infectious diseases. He has ...
December 7, 2021 Speaker: Steve Smith, PhD Approximately 7% -9% of the global population suffers from autoimmune diseases. Innate Immunotherapy Responses in Mouse and Humanized Since the first immune checkpoint blocker ipilimumab was approved by the US FDA in 2011, more drug companies have sought to ... Translational challenges in immunotherapy impede the successful transition of many therapeutic candidates to the clinic. Speaker: Dr. Juan Hong, Business Development Manager of International Department at Shanghai